3 results match your criteria: "Päijät-Häme Central Hospital in Lahti[Affiliation]"
Acta Neurol Scand
January 2013
Department of Neurology, Päijät-Häme Central Hospital in Lahti, Finland.
Objectives: A variety of neurological and psychiatric disorders have recently been linked to coeliac disease and gluten sensitivity. We here explored whether persistently positive gliadin antibodies (AGA) and coeliac-type HLA increase the risk of gluten sensitivity-related neurological and psychiatric manifestations. The study was carried out in an older population who had consumed gluten for decades but who had no previous coeliac disease diagnosis.
View Article and Find Full Text PDFDig Liver Dis
October 2011
Department of Neurology, Päijät-Häme Central Hospital in Lahti, Finland.
Background: The specificity of the conventional gliadin antibody test is considered low.
Aims: We explored whether gliadin antibody(AGA)-positivity without tissue transglutaminase antibodies (tTGA) is persistent in the elderly population and whether such positivity indicates overt or potential coeliac disease in genetically predisposed individuals.
Methods: AGA and tissue transglutaminase antibody were measured in 2089 elderly individuals twice with a three-year interval.
Scand J Gastroenterol
October 2010
Department of Neurology, Päijät-Häme Central Hospital in Lahti, Finland.
Objective: Antigliadin antibodies (AGA) show good sensitivity but low specificity for celiac disease and can also be found in healthy individuals. However, data suggest that AGA positivity might be related to distinct disease entities such as allergy and gluten ataxia. Our aim here is to explore the clinical relevance of positive AGA in the elderly population.
View Article and Find Full Text PDF